Loading...
Inhaled Levosimendan versus Intravenous Levosimendan in Patients with Pulmonary Hypertension Undergoing Mitral Valve Replacement
CONTEXT: Inhaled levosimendan may act as selective pulmonary vasodilator and avoid systemic side effects of intravenous levosimendan, which include decrease in systemic vascular resistance (SVR) and systemic hypotension, but with same beneficial effect on pulmonary artery pressure (PAP) and right ve...
Na minha lista:
| Udgivet i: | Ann Card Anaesth |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Medknow Publications & Media Pvt Ltd
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6078018/ https://ncbi.nlm.nih.gov/pubmed/30052230 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/aca.ACA_19_18 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|